Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for ...

Sepsis is a life-threatening condition in which the body overreacts to an infection and starts attacking its own tissues and ...

The transition from sepsis to severe sepsis The initial presentation of severe sepsis and septic shock is often nonspecific, and its severity, cryptic. Patients who arrive with a relatively benign or ...

Spectral is a Phase 3 company seeking U.S. FDA approval for its unique product for the treatment of patients with septic shock, Toraymyxin™ (“PMX”). PMX is a therapeutic hemoperfusion device that ...

More information: Nicholas A. Bosch et al, Comparative Effectiveness of Fludrocortisone and Hydrocortisone vs Hydrocortisone Alone Among Patients With Septic Shock, JAMA Internal Medicine (2023).

Septicemia or sepsis is caused by bacteria, viruses and fungi. ‘Adding fludrocortisone to hydrocortisone lowered the absolute risk difference to 3.7% in septic shock patients.’ ...

Among patients with solid tumors, septic shock was associated with a 69.4% 28-day mortality rate, according to a study published in CHEST.“Even though septic shock is a well-recognized deadly ...

Septic shock remained significantly associated with increased 28-day mortality among patients with hematologic malignancies, according to study results published in Journal of the National ...